首页> 外文OA文献 >Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

【2h】

Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial

机译：对健康状生活质量的影响使NAB-PABLITAXEL与转移性胰腺癌患者组合的一线疗法的无核治疗的恶化存活率是转移性胰腺癌的患者：随机阶段AFUGEM Gercor临床试验结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Emilie Charton; Jean‐Baptiste Bachet; Pascal Hammel; Jérôme Desramé; Benoist Chibaudel; Romain Cohen; Philippe Debourdeau; Jérome Dauba; Thierry Lecomte; Jean‐François Seitz; Christophe Tournigand; Thomas Aparicio; Véronique Guerin‐Meyer; Julien Taieb; Julien Volet; Christophe Louvet; Amélie Anota; Franck Bonnetain;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 改良FOLFIRINOX方案一线化疗中国转移性胰腺癌患者的疗效与安全性研究 [J] . Zhi-Qiang Wang, Rui-Hua Xu, Yi Ba, 癌症（英文版） . 2019,第008期
2. 索拉非尼与舒尼替尼一线治疗中国转移性肾细胞癌患者的疗效、安全性和生活质量的比较 [J] . Wen Cai, Wen Kong, Baijun Dong, 癌症（英文版） . 2018,第003期
3. Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial [J] . Emilie Charton, Jean‐Baptiste Bachet, Pascal Hammel, Cancer Medicine . 2019,第11期

机译：对健康状生活质量的影响使NAB-PABLITAXEL与转移性胰腺癌患者组合的一线疗法的无核治疗的恶化存活率是转移性胰腺癌的患者：随机阶段AFUGEM Gercor临床试验结果
4. Impact on time until deterioration of health-related quality of life of a first-line therapy combining ABI-007 and gemcitabine or simplified LV5FU2 in patients with metastatic pancreatic cancer: results of clinical phase II trial AFUGEM [J] . Charton Emilie, Bachet Jean-Baptiste, Chibaudel Benoist, Quality of life research: An international journal of quality of life aspects of treatment, care and rehabilitation . 2016,第Suppla1期

机译：转移性胰腺癌患者联合ABI-007和吉西他滨或简化的LV5FU2一线治疗对健康相关生活质量恶化的时间影响：临床II期试验AFUGEM的结果
5. A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial [J] . Jean-Baptiste Bachet, Benoist Chibaudel, Franck Bonnetain, BMC Cancer . 2015,第1期

机译：每周一次nab-紫杉醇联合吉西他滨或简化的LV5FU2作为转移性胰腺癌患者的一线治疗的II期随机研究：AFUGEM GERCOR试验
6. Preliminary results of a phase I/II clinical trial using in situ photoimmunotherapy combined with imiquimod for metastatic melanoma patients [C] . Xiaosong Li, Mark F. Naylor, Robert E. Nordquist, . 2010

机译：使用原位光免疫疗法联合咪喹莫特治疗转移性黑色素瘤患者的I / II期临床试验的初步结果
7. Evaluation of a randomized clinical trial of a psychoeducational intervention on long-term quality of life, negative affect, progression and survival in head and neck cancer patients. [D] . Trevino, Lara A. 2011

机译：心理教育干预对头颈部癌症患者的长期生活质量，负面影响，进展和生存的随机临床试验评估。
8. Impact on health‐related quality of life deterioration‐free survival of a first‐line therapy combining nab‐paclitaxel plus either gemcitabine or simplified leucovorin and fluorouracil for patients with metastatic pancreatic cancer: Results of the randomized phase II AFUGEM GERCOR clinical trial [O] . Emilie Charton, Jean‐Baptiste Bachet, Pascal Hammel, 2019

机译：转移性胰腺癌联合纳布紫杉醇联合吉西他滨或简化的亚叶酸钙和氟尿嘧啶一线治疗对与健康相关的生活质量的无恶化生存期的影响：AFUGEM GERCOR II期随机临床试验结果
9. A randomized phase II study of weekly nab-paclitaxel plus gemcitabine or simplified LV5FU2 as first-line therapy in patients with metastatic pancreatic cancer: the AFUGEM GERCOR trial [O] . Jean-Baptiste Bachet, null null, Benoist Chibaudel, 2015

机译：每周一次nab-紫杉醇联合吉西他滨或简化的LV5FU2作为转移性胰腺癌患者的一线治疗的II期随机研究：AFUGEM GERCOR试验

著录项

引文网络

相似文献

相关主题

期刊订阅